Skip to main content

Baker Bros. Advisors Lp

Source: SEC Form 13F · as of Mar 2026

Baker Bros. Advisors Lp holds 49 biotech & pharma companies tracked by BioSniper, totaling $12.55B in value as of Mar 2026 (SEC Form 13F).

Companies held

49

Total value held

$12.55B

BioSniper AIPage evidence connected

Prepared research question

What matters most for Incyte Corp. (INCY)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
INCYIncyte Corp.30,744,412$2.89B
ONCBeOne Medicines Ltd.8,799,053$2.61B
INSMINSMED Inc7,421,111$1.21B
ACADACADIA PHARMACEUTICALS INC42,896,690$954.9M
RVMDREVOLUTION MEDICINES, INC.9,555,357$929.3M
KODKodiak Sciences Inc.19,919,186$759.3M
SMMTSummit Therapeutics Inc.36,391,063$690.0M
RYTMRHYTHM PHARMACEUTICALS, INC.5,604,483$487.4M
IONSIONIS PHARMACEUTICALS INC2,047,727$153.8M
KNSAKiniksa Pharmaceuticals International, plc2,826,246$136.1M
IMVTImmunovant, Inc.5,457,881$135.6M
ROIVRoivant Sciences Ltd.4,867,723$134.8M
ARWRARROWHEAD PHARMACEUTICALS, INC.1,992,783$124.9M
STOKStoke Therapeutics, Inc.3,336,697$108.6M
IMTXImmatics N.V.10,916,693$107.4M
ABCLAbCellera Biologics Inc.30,275,938$105.7M
ABVXAbivax SA875,796$97.5M
NRIXNurix Therapeutics, Inc.4,658,556$72.2M
DNLIDenali Therapeutics Inc.3,731,695$71.6M
DNTHDianthus Therapeutics, Inc. /DE/852,164$71.5M
GPCRStructure Therapeutics Inc.1,432,529$69.0M
TRDAEntrada Therapeutics, Inc.5,072,730$64.0M
BCYCBICYCLE THERAPEUTICS PLC10,885,357$50.5M
SYRESpyre Therapeutics, Inc.1,000,000$50.4M
ALMSALUMIS INC.2,012,500$44.3M
VRDNViridian Therapeutics, Inc.\DE1,971,678$38.6M
ELVNEnliven Therapeutics, Inc.905,191$35.5M
PRLDPrelude Therapeutics Inc10,123,824$34.6M
DSGNDesign Therapeutics, Inc.2,585,978$27.5M
CNTACentessa Pharmaceuticals plc670,751$26.6M
CTMXCytomX Therapeutics, Inc.4,975,826$23.4M
JBIOJade Biosciences, Inc.1,641,137$23.1M
IRONDisc Medicine, Inc.349,657$22.4M
IMCRImmunocore Holdings plc734,397$22.1M
CLDXCelldex Therapeutics, Inc.665,370$21.1M
NGNENeurogene Inc.991,691$20.0M
TECXTectonic Therapeutic, Inc.607,788$18.8M
ARGXARGENX SE25,174$18.4M
SIONSionna Therapeutics, Inc.400,000$16.0M
CMPSCOMPASS Pathways plc2,344,720$13.0M
PHVSPharvaris N.V.375,000$10.6M
RCUSArcus Biosciences, Inc.415,621$9.0M
MPLTMapLight Therapeutics, Inc.364,705$7.4M
ABSIAbsci Corporation2,134,803$6.4M
SGMTSagimet Biosciences Inc.952,996$5.0M
LBRXLB PHARMACEUTICALS INC200,000$4.9M
SKYESkye Bioscience, Inc.1,575,243$968K
SANASana Biotechnology, Inc.310,483$894K
ALGSAligos Therapeutics, Inc.83,055$617K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.